The goal of this study was to evaluate the effects of ractopamine-hydrochloride (RAC) supplementation on the myosin heavy chain isoform distribution and shelf-life properties of muscles from beef top round, knuckle, and loin. Thirty-four steer carcasses were selected from 4 separate slaughter groups. Within each slaughter group (3 groups, n = 8; 1 group, n = 10), steers were separated into pens (n = 8) and fed 0 or 200 mg x animal(-1) x d(-1) of RAC for the final 28 d of feeding. Seventy-two hours postmortem, the longissimus lumborum, semimembranosus (SM), adductor, gracilis, vastus lateralis (VL), and rectus femoris were removed from each carcass. A subsample of each muscle was collected for immunohistochemical analysis. Whole muscles were vacuum packaged and wet aged at 1 +/- 2 degrees C for 13 d before processing into steaks for a 5-d simulated retail display study. Daily, steaks were analyzed for reduction of nitric oxide metmyoglobin, lean color, fat color, and surface discoloration. Objective measures of metmyoglobin, oxymyoglobin, L*, a*, and b* values were recorded daily. Ractopamine significantly (P < 0.05) changed the fiber type isoform distribution in all muscles except the SM. The VL and gracilis presented the greatest fiber type switch with approximately 21% of type I fibers switching to type IIA fibers. However, the fiber type shifts induced by RAC supplementation had little to no effect on subjective and objective color measurements during the 5-d retail display period. Metmyoglobin and oxymyoglobin accumulation, L*, a*, and b*-values were not affected (P > 0.05) by RAC supplementation. Percent nitric oxide metmyoglobin reduction data indicate that reducing ability of RAC-treated steaks from the adductor and longissimus lumborum were significantly affected (P < 0.05). Visual panel data suggest that RAC tended (P < 0.10) to have the most detrimental effect on the lean color and surface discoloration scores of steaks from the VL during the last 3 d of display. Ractopamine significantly (P < 0.05) increased the surface discoloration of the rectus femoris and SM on d 5. Although RAC supplementation had no effect on objective color measurements, subjective measurements indicate that it may have some effect on surface discoloration of some muscles.
Primiparous, spring-calving Brahman cows (BW = 425.0 +/- 13.8 kg, body condition score [BCS] = 5.0 +/- .2 units; SEM) were used to study the effects of thyroid manipulation on weight gain, milk production, and reproduction. Nine cows served as controls. Nine cows were induced to become hypothyroid by daily ingestion of 4 mg/kg BW of 6-n-propyl-2-thiouracil (PTU). Cows were stratified to treatment 1 d after calving based on season of birth, BW, BCS, calf sex, and calf sire. The treatment period lasted for 84 d and was followed by a 56-d posttreatment period. Cow BW, BCS, and calf weight were recorded twice weekly. Milk production was estimated at 14, 28, 56, 84, 98, 112, and 140 d after calving. Weekly blood samples were obtained for analysis of triiodothyronine (T3), thyroxine (T4), and progesterone (P4). Estrus was monitored twice daily with the aid of a fertile bull equipped with a chin ball marker. Hypothyroidism was effectively induced in all PTU cows during the treatment period. The PTU cows gained more (P = .002) weight (54.6 +/- 7.6 kg) and tended (P = .06) to increase body condition (.61 +/- .17 units) more than control cows (15.7 +/- 7.6 kg; .11 +/- .17 units) during the treatment period. Control calves gained at a faster rate (.85 +/- .04 kg/d; P < .01) than PTU calves (.70 +/- .04 kg/d) during the treatment period. Milk production was lower (P < .05) in PTU cows on d 56 and 84. During posttreatment all trends were reversed, and BW, BCS, calf weight, and milk production were similar between the two groups by d 140. Reproductive performance was not affected by induction of hypothyroidism. In conclusion, induction of hypothyroidism was successful in increasing cow weight and BCS gains and suppressing milk production during the treatment period, but these changes were not successful in improving reproductive performance of primiparous Brahman cows.
To evaluate the effects of hypothyroidism on ovarian function, multiparous, nonlactating Brahman cows (n = 18) were assigned randomly to dietary treatments containing either 0 (C; n = 9) or 4 mg x kg BW(-1) x d(-1) 6-n-propyl-2-thiouracil (PTU; n = 9), to suppress thyroid function, in the feed concentrate. Weekly changes in BW and body condition score (BCS) were recorded. Dietary treatments began on d 10 of the estrous cycle. Ten days after the first treatment estrus, all cows received daily i.m. injections of 25 IU of porcine FSH over a 3-d period. Seven days after AI, embryos were collected nonsurgically, and the ovaries were removed via midflank laparotomy. Based on thyroxine (T4) concentrations after 49 d of treatment, five cows were hypothyroid (H-PTU) and four were partially suppressed (P-PTU). Cows in the PTU group had greater (P<.01) ADG, (P<.05) ovarian weights, and numbers of large (> or =8 mm) (P<.05) follicles. Cows in the PTU group had lower embryo recovery rate (P<.001), fertilization rate (P<.001), and percentage of blastocysts (P<.1) than C cows. The H-PTU cows had greater numbers of luteinized follicles (P<.06), greater concentrations of progesterone (P4) in the follicular fluid at all size categories (P<.1), and greater numbers of corpora lutea (P<.05) than C cows. The ratio of luteal to serum P4 on d 7 was greater (P<.05) in hypothyroid cows. Induced hypothyroidism improved weight gain and BCS, increased ovarian response to FSH, and affected ovulation, fertility, and P4 secretion in superovulated Brahman cows.
The objective of this experiment was to examine the effect of castration technique on daily feed intake (DFI), daily water intake (DWI), growth performance, residual feed intake (RFI), and inflammatory response in weaned beef calves. Seventy-five beef calves (214 ± 3.2 kg; 200 ± 26 d of age) were housed in a GrowSafe 4000 feed intake facility 7 d post weaning (15 calves/pen). Calves were offered a total mixed ration (TDN = 67.3% and CP = 12.2%, DM = 89%) for ad libitum consumption. On d 0, calves were assigned to 1 of 5 treatments (n = 15 calves/treatment): 1) steers castrated surgically pre-weaning (52 d of age; CON); 2) intact bulls (BULL); 3) bulls castrated by the Callicrate Bander on d 0 (No-Bull Enterprises LLC.; BAN); 4) bulls castrated by the Henderson Castrating Tool on d 0 (Stone Mfg & Supply Co.; HEN); and 5) bulls castrated surgically utilizing an emasculator on d 0 (SUR). Average daily gain, DFI, and DWI were recorded over 84 d. Blood was collected from a sub-sample of calves (n = 45) on d 0, 2, 6, 9, 12, and 15 relative to castration. Castration decreased (P = 0.06) ADG for castrates compared with CON from d 0 to 14 but not d 0 to 84. Daily feed intake and DWI were similar (P > 0.10) among treatments during d 0 to 84. Gain:feed was not affected by castration technique; however, RFI tended (P = 0.09) to be negative for CON and BULL compared with castrates on d 0 to 14 but not d 0 to 84. Acute phase protein analyses indicated that surgical castration (SUR or HEN) elicited a short-term inflammatory response in calves, whereas calves castrated with BAN elicited a delayed response. Calves castrated pre-weaning had improved d 0 to 14 ADG, feed intake, and inflammation response compared with calves castrated at weaning. Banding elicited a delayed negative response in ADG, DWI, and inflammation. In weaned calves, castration method did not affect performance, DFI, DWI, or inflammatory response during the 84-d trial.
Prepubertal Brahman heifers (BW = 302 +/- 7.5 kg, body condition score [BCS] = 5.4 +/- .2, age = 498 +/- 3.4 d: SEM) were used to study the effects of thyroid function on growth and reproduction. Seven heifers were controls (C). Seven heifers were induced to become hypothyroid by ingestion of 4 mg/kg BW of 6-n-propyl-2-thiouracil (PTU). Seven heifers were induced to become hyperthyroid (T) by daily s.c. injections of triiodothyronine (T3, 1 mg/d). Treatments were administered for 84 d followed by an 84 d posttreatment period. Blood samples were obtained twice weekly via tail venipuncture for analysis of T3, thyroxine, and progesterone. The BW, BCS, and rectal temperature (RT) were recorded weekly. Estrus was monitored twice daily with the aid of a fertile bull equipped with a chin ball marker. Hyperthyroidism and hypothyroidism were successfully induced in T- and PTU- treated heifers, respectively. During the treatment period, PTU heifers gained the most BW and BCS (72.4 +/- 5.4 kg; .93 +/- .15 units), C heifers were intermediate (41.7 +/- 5.4 kg; .43 +/- .15 units), and T heifers gained the least (13.3 +/- 5.4 kg; -.36 +/- .15 units; P < .05). The RT also decreased (P < .05) in PTU heifers (-1.9 +/- .2 degrees C) compared with C (-1.2 +/- .2 degrees C) or T heifers (-.8 +/- .2 degrees C). No heifers exhibited estrus during the treatment period. During the posttreatment period, T heifers gained the most BW and BCS (93.9 +/- 6.1 kg; 1.14 +/- .13 units), C heifers were intermediate (67.0 +/- 6.1 kg; .86 +/-. 13 units), and PTU heifers gained the least (22.2 +/- 6.1 kg; -.14 +/- .13 units; P < .05). The reversal in BW and BCS gains during the posttreatment period corresponded to periods of transient hypo- and hyperthyroidism in T and PTU heifers, respectively. Age and BW at puberty and pregnancy were similar among all treatment groups. The BCS for T heifers was lower (5.7 +/- .2 units; P < .05) at puberty and pregnancy than for PTU heifers (6.6 +/- .2 units). Induction of hypothyroidism resulted in significant increases in BW and BCS during the treatment period, but these increases were not sufficient to dramatically affect reproductive performance of Brahman heifers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.